TY - JOUR
T1 - Noninvasive prediction of portal pressure with MR elastography and DCE-MRI of the liver and spleen
T2 - Preliminary results
AU - Wagner, Mathilde
AU - Hectors, Stefanie
AU - Bane, Octavia
AU - Gordic, Sonja
AU - Kennedy, Paul
AU - Besa, Cecilia
AU - Schiano, Thomas D.
AU - Thung, Swan
AU - Fischman, Aaron
AU - Taouli, Bachir
N1 - Funding Information:
Contract grant sponsor: National Institutes of Health (NIH); contract grant number: 1R01DK08787; Contract grant sponsor: SociétéFranc¸aise de Radiologie; Contract grant sponsor: Schweizerischer Nationalfonds zur F€orderung der Wissenschaftlichen Forschung; contract grant number: P2ZHP3_161691
Publisher Copyright:
© 2018 International Society for Magnetic Resonance in Medicine
PY - 2018/10
Y1 - 2018/10
N2 - Background: Portal hypertension (PH), defined by hepatic venous pressure gradient (HVPG) ≥5 mmHg and clinically significant PH, defined by HVPG ≥10 mmHg, are complications of chronic liver disease. Purpose: To assess the diagnostic performance of MR elastography (MRE) and dynamic contrast-enhanced MRI (DCE-MRI) of the liver and spleen for the prediction of PH and clinically significant PH, in comparison with a qualitative PH imaging scoring system. Study Type: IRB-approved prospective study. Population: In all, 34 patients with chronic liver disease who underwent HVPG measurement. Field Strength/Sequence: 1.5/3T examination including 2D-GRE MRE (n = 33) and DCE-MRI of the liver/spleen (n = 28). Assessment: Liver and spleen stiffness were calculated from elastogram maps. DCE-MRI was analyzed using model-free parameters and pharmacokinetic modeling. Two observers calculated qualitative PH imaging scores based on routine images. Statistical Tests: Imaging parameters were correlated with HVPG. Receiver operating characteristic (ROC) analysis was performed for prediction of PH and clinically significant PH. Results: There were significant correlations between DCE-MRI parameters (liver time-to-peak, r = 0.517 / P = 0.006, liver distribution volume, r = 0.494 / P = 0.009, liver upslope, r = –0.567 / P = 0.002), liver stiffness (r = 0.478 / P = 0.016), PH imaging score (r = 0.441 / P = 0.009), and HVPG. ROC analysis provided significant area under the ROC (AUROCs) for PH (liver upslope 0.765, liver stiffness 0.809, spleen volume/diameter 0.746–0.731, PH imaging score 0.756) and for clinically significant PH (liver and spleen perfusion parameters 0.733–0.776, liver stiffness 0.742, PH imaging score 0.742). The ratio of liver stiffness to liver upslope had the highest AUROC for diagnosing PH (0.903) and clinically significant PH (0.785). Data Conclusion: These preliminary results suggest that the combination of liver stiffness and perfusion metrics provide excellent accuracy for diagnosing PH, and fair accuracy for clinically significant PH. Combined MRE and DCE-MRI outperformed qualitative imaging scores for prediction of PH. Level of Evidence: 1. Technical Efficacy: Stage 2. J. Magn. Reson. Imaging 2018;48:1091–1103.
AB - Background: Portal hypertension (PH), defined by hepatic venous pressure gradient (HVPG) ≥5 mmHg and clinically significant PH, defined by HVPG ≥10 mmHg, are complications of chronic liver disease. Purpose: To assess the diagnostic performance of MR elastography (MRE) and dynamic contrast-enhanced MRI (DCE-MRI) of the liver and spleen for the prediction of PH and clinically significant PH, in comparison with a qualitative PH imaging scoring system. Study Type: IRB-approved prospective study. Population: In all, 34 patients with chronic liver disease who underwent HVPG measurement. Field Strength/Sequence: 1.5/3T examination including 2D-GRE MRE (n = 33) and DCE-MRI of the liver/spleen (n = 28). Assessment: Liver and spleen stiffness were calculated from elastogram maps. DCE-MRI was analyzed using model-free parameters and pharmacokinetic modeling. Two observers calculated qualitative PH imaging scores based on routine images. Statistical Tests: Imaging parameters were correlated with HVPG. Receiver operating characteristic (ROC) analysis was performed for prediction of PH and clinically significant PH. Results: There were significant correlations between DCE-MRI parameters (liver time-to-peak, r = 0.517 / P = 0.006, liver distribution volume, r = 0.494 / P = 0.009, liver upslope, r = –0.567 / P = 0.002), liver stiffness (r = 0.478 / P = 0.016), PH imaging score (r = 0.441 / P = 0.009), and HVPG. ROC analysis provided significant area under the ROC (AUROCs) for PH (liver upslope 0.765, liver stiffness 0.809, spleen volume/diameter 0.746–0.731, PH imaging score 0.756) and for clinically significant PH (liver and spleen perfusion parameters 0.733–0.776, liver stiffness 0.742, PH imaging score 0.742). The ratio of liver stiffness to liver upslope had the highest AUROC for diagnosing PH (0.903) and clinically significant PH (0.785). Data Conclusion: These preliminary results suggest that the combination of liver stiffness and perfusion metrics provide excellent accuracy for diagnosing PH, and fair accuracy for clinically significant PH. Combined MRE and DCE-MRI outperformed qualitative imaging scores for prediction of PH. Level of Evidence: 1. Technical Efficacy: Stage 2. J. Magn. Reson. Imaging 2018;48:1091–1103.
KW - dynamic-contrast enhanced MRI
KW - magnetic resonance elastography
KW - magnetic resonance imaging
KW - portal hypertension
UR - http://www.scopus.com/inward/record.url?scp=85045295636&partnerID=8YFLogxK
U2 - 10.1002/jmri.26026
DO - 10.1002/jmri.26026
M3 - Article
C2 - 29638020
AN - SCOPUS:85045295636
SN - 1053-1807
VL - 48
SP - 1091
EP - 1103
JO - Journal of Magnetic Resonance Imaging
JF - Journal of Magnetic Resonance Imaging
IS - 4
ER -